Skip to main content
Top

Multiple myeloma complicated with spinal infiltration: a case report

Excerpt

MM is a frequently encountered malignant hematological disorder, typically localized within the bone marrow. A subset of patients may develop extramedullary manifestations, with metastasis to other soft tissues and potential involvement of multiple organs and tissues, either as the initial presenting symptom or concurrently. Literature indicates that the incidence of extramedullary spread at the time of diagnosis of multiple myeloma ranges from 7 to 18%, with an additional 20% experiencing extramedullary spread during the course of treatment [1]. Extramedullary plasmacytomas (EMPs) within the spinal canal can precipitate severe spinal cord compression syndrome (SCCS), which is characterized by rapid disease progression. Despite this, there remains a significant debate surrounding the optimal management of MM patients who develop SCCS. …
Title
Multiple myeloma complicated with spinal infiltration: a case report
Authors
Man Guo
Guohui Zhao
Zhenyu Zhang
Jie Zhou
Publication date
10-09-2025
Publisher
Springer International Publishing
Published in
Neurological Sciences
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-025-08481-4
This content is only visible if you are logged in and have the appropriate permissions.

2025 ESMO Congress hub

Unlock your free and exclusive access to expert interviews, news, and more from the annual congress of the European Society for Medical Oncology.

Read more

Keynote webinar | Spotlight on progress in colorectal cancer

  • Live
  • Webinar | 11-12-2025 | 18:00 (CET)

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Watch it live: Thursday 11 December 2025, 18:00-19:30 (CET)

Prof. Antoni Castells
Prof. Edward Giovannucci
Developed by: Springer Medicine
Join the webinar
Webinar
SPONSORED

Masterclass webinar: Expert review of CAR T-cell therapy patient cases in R/R DLBCL or R/R FL

Join Professor Joy Ho as she leads a panel of Asia-Pacific-based experts, discussing real-life patient cases and their experiences with CAR T-cell therapy for the treatment of R/R DLBCL or R/R FL. Learn about how to identify appropriate patients for CAR T-cell therapy and how to optimize outcomes with this treatment modality. Gain insights into essential aspects of pre- and post-infusion management, as well as important considerations for treatment sequencing.

This educational activity is not intended for healthcare professionals based in the UK, US, or off-label Asia-Pacific countries.

Sponsored by:
  • Novartis Pharma AG
Prof. Joy Ho
Prof. William Hwang
Dr. Kentaro Fukushima
Prof. Dok Hyun Yoon
Prof. Miki Ando
Developed by: Springer Health+
Learn more
Image Credits
Imaging of patient with multiple myeloma and spinal infiltration/© 2025, Fondazione Società Italiana di Neurologia, Neurol Sci (used with permission), Cancer cell screening and treatment concept/© artacet / iStock / Getty Images Plus, Colon cancer illustration/© (M) KATERYNA KON/SCIENCE PHOTO LIBRARY / Getty Images, CAR T-cell attacking cancer cells/© LoveLive/stock.adobe.com